Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

• Status: Completed
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Chloroquine or hydroxychloroquine in COVID-19 treatment

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Chloroquine; Chloroquine diphosphate; Hydroxychloroquine

Criteria

Inclusion Criteria:

• Covid 19 patients

Exclusion Criteria:

• Allergy or contraindication to the drug

• Pregnant or lactating

• Patients with cardiac problems